Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian equity markets trade weak
Tue, 23 Oct 11:30 am

Indian equity markets continue to trade weak over the last two hours of trade. Capital goods and realty stocks witnessed maximum buying interest while oil and gas and Consumer Durable stocks witnessed maximum selling pressure.

The Sensex today is down by 15 points, while the NSE-Nifty today is down by 7 points. BSE Mid Cap index and the BSE Small Cap index are up by 0.29% and 0.29%. The rupee is trading at 53.56 to the US dollar.

Pharma stocks are trading in the green led by Wockhardt Limited and Torrent Pharma. According to a leading financial daily, Dr Reddy's Laboratories Limited has offered to buy OctoPlus NV, for an offer price of Rs 1.9 bn in cash. OctoPlus is a service based specialty pharmaceutical company. Dr Reddy's currently holds an irrevocable commitment from shareholders representing over 50% of OctoPlus' issued and outstanding shares. Further, the Executive Board and the Supervisory Board of OctoPlus have unanimously recommended the offer to the remaining shareholders. This deal will help expand the expertise and scientific capabilities of Dr Reddy's. Dr Reddy's will provide OctoPlus with fee for service and milestone payments as consideration for services it will render for a maximum of £ 2 m over the next six months.

Auto stocks are trading weak led by Tube Investments and Hero MotoCorp. According to a leading financial daily, Hero MotoCorp has joined hands with HDFC Bank to offer financing at 6.99% across its entire range of products. This is to cash in on the festive season. The company claimed it has retailed over 1.5 lakh two-wheelers during the Navratras till Sunday evening, as it seeks to meet a target despatching half a million two-wheelers during this month. As per industry estimates, the existing interest rate on two-wheeler finance is around 10%. The company has set a target of despatching over half a million two-wheelers in October including more than 1.5 lakh Splendor bikes to meet the market demand in the weeks leading up to Diwali in November. The company is banking on the festive season to boost sagging sales.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian equity markets trade weak". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.